Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Side effects of therapy of hepatitis C and their management.

Fried MW.

Hepatology. 2002 Nov;36(5 Suppl 1):S237-44. Review.

PMID:
12407599
[PubMed - indexed for MEDLINE]
2.

Hematologic side effects of interferon and ribavirin therapy.

Kowdley KV.

J Clin Gastroenterol. 2005 Jan;39(1 Suppl):S3-8. Review.

PMID:
15597025
[PubMed - indexed for MEDLINE]
3.

Safety of peginterferon in the treatment of chronic hepatitis C.

Hashemi N, Rossi S, Navarro VJ, Herrine SK.

Expert Opin Drug Saf. 2008 Nov;7(6):771-81. doi: 10.1517/14740330802423291 . Review.

PMID:
18983223
[PubMed - indexed for MEDLINE]
4.

Peginterferon-alpha-2a (40kD) plus ribavirin: a review of its use in the management of chronic hepatitis C.

Keating GM, Curran MP.

Drugs. 2003;63(7):701-30. Review.

PMID:
12656650
[PubMed - indexed for MEDLINE]
5.

The management of side-effects during therapy for hepatitis C.

Aspinall RJ, Pockros PJ.

Aliment Pharmacol Ther. 2004 Nov 1;20(9):917-29. Review.

PMID:
15521838
[PubMed - indexed for MEDLINE]
Free Article
6.

Managing hepatitis C.

Bacon BR.

Am J Manag Care. 2004 Mar;10(2 Suppl):S30-40. Review.

PMID:
15084065
[PubMed - indexed for MEDLINE]
Free Article
7.

Peginterferon-alpha(2b) and ribavirin.

Ahn J, Flamm S.

Expert Rev Anti Infect Ther. 2004 Feb;2(1):17-25. Review.

PMID:
15482168
[PubMed - indexed for MEDLINE]
8.

[Complementary treatments of chronic viral hepatitis C].

Thevenot T, Di Martino V, Lunel-Fabiani F, Vanlemmens C, Becker MC, Bronowicki JP, Bresson-Hadni S, Miguet JP.

Gastroenterol Clin Biol. 2006 Feb;30(2):197-214. Review. French.

PMID:
16565651
[PubMed - indexed for MEDLINE]
Free Article
9.

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.

Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J.

Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. Review.

PMID:
15461877
[PubMed - indexed for MEDLINE]
Free Article
10.

Treatment options for patients with hepatitis C: role of pharmacists in optimizing treatment response and managing adverse events.

Smith JP.

Pharmacotherapy. 2008 Sep;28(9):1151-61. doi: 10.1592/phco.28.9.1151. Review.

PMID:
18752386
[PubMed - indexed for MEDLINE]
11.

Side effects of therapy for chronic hepatitis C.

Russo MW, Fried MW.

Gastroenterology. 2003 May;124(6):1711-9. Review. No abstract available.

PMID:
12761728
[PubMed - indexed for MEDLINE]
12.

[Changes in the management of patients with side effects from the treatment of hepatitis C].

Bezemer G, Schalm SW, van Gool AR, de Knegt RJ.

Ned Tijdschr Geneeskd. 2007 Mar 3;151(9):525-30. Review. Dutch.

PMID:
17373393
[PubMed - indexed for MEDLINE]
13.

Using pegylated interferon and ribavirin to treat patients with chronic hepatitis C.

Ward RP, Kugelmas M.

Am Fam Physician. 2005 Aug 15;72(4):655-62. Review. Erratum in: Am Fam Physician. 2007 Mar 15;75(6):808.

PMID:
16127955
[PubMed - indexed for MEDLINE]
Free Article
14.

Peginterferon and ribavirin in HCV: improvement of sustained viral response.

Ferenci P.

Best Pract Res Clin Gastroenterol. 2008;22(6):1109-22. doi: 10.1016/j.bpg.2008.11.001. Review.

PMID:
19187870
[PubMed - indexed for MEDLINE]
15.

Current therapy for hepatitis C: pegylated interferon and ribavirin.

McHutchison JG, Fried MW.

Clin Liver Dis. 2003 Feb;7(1):149-61. Review.

PMID:
12691464
[PubMed - indexed for MEDLINE]
16.

Into the light: strategies for battling hepatitis C.

Bacon BR, McHutchison JG.

Am J Manag Care. 2007 Dec;13 Suppl 12:S319-26. Review.

PMID:
18095780
[PubMed - indexed for MEDLINE]
Free Article
17.

The use of growth factors to manage the hematologic side effects of PEG-interferon alfa and ribavirin.

Collantes RS, Younossi ZM.

J Clin Gastroenterol. 2005 Jan;39(1 Suppl):S9-13. Review.

PMID:
15597026
[PubMed - indexed for MEDLINE]
18.

[Difficult-to-treat patients with chronic hepatitis C].

Zeuzem S.

Praxis (Bern 1994). 2006 Sep 20;95(38):1459-64. Review. German.

PMID:
17058596
[PubMed - indexed for MEDLINE]
19.

Adult respiratory distress syndrome after treatment with pegylated interferon alpha-2a and ribavirin.

Vartany E, Caldwell CA, Trow TK.

Heart Lung. 2008 Mar-Apr;37(2):153-6. doi: 10.1016/j.hrtlng.2007.10.002. Review.

PMID:
18371508
[PubMed - indexed for MEDLINE]
20.

Pegylated interferon plus ribavirin for the treatment of chronic hepatitis C.

Baker DE.

Rev Gastroenterol Disord. 2003 Spring;3(2):93-109. Review.

PMID:
12776006
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk